Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 50 | 2024 | 1959 | 4.240 |
Why?
|
Fatty Liver | 12 | 2024 | 807 | 2.180 |
Why?
|
Bariatric Surgery | 9 | 2021 | 1013 | 1.440 |
Why?
|
Elasticity Imaging Techniques | 9 | 2024 | 395 | 1.430 |
Why?
|
Liver | 41 | 2024 | 7574 | 1.410 |
Why?
|
Hepatitis C | 11 | 2022 | 1593 | 1.200 |
Why?
|
Thiazolidinediones | 4 | 2021 | 462 | 1.140 |
Why?
|
Cardiovascular Diseases | 18 | 2024 | 15649 | 1.140 |
Why?
|
Dyslipidemias | 5 | 2019 | 873 | 1.070 |
Why?
|
Hepatitis C, Chronic | 10 | 2020 | 1031 | 0.970 |
Why?
|
Lipoproteins | 3 | 2024 | 880 | 0.950 |
Why?
|
End Stage Liver Disease | 5 | 2024 | 370 | 0.950 |
Why?
|
Carcinoma, Hepatocellular | 16 | 2024 | 2336 | 0.910 |
Why?
|
Vitamin E | 3 | 2019 | 874 | 0.910 |
Why?
|
HIV Infections | 17 | 2024 | 17575 | 0.750 |
Why?
|
Obesity, Morbid | 7 | 2021 | 1309 | 0.730 |
Why?
|
Liver Neoplasms | 16 | 2024 | 4365 | 0.730 |
Why?
|
Growth Hormone-Releasing Hormone | 5 | 2021 | 128 | 0.690 |
Why?
|
Antiviral Agents | 9 | 2020 | 3064 | 0.680 |
Why?
|
Disease Susceptibility | 4 | 2023 | 1794 | 0.650 |
Why?
|
Gastroenterology | 4 | 2020 | 589 | 0.650 |
Why?
|
Obesity | 18 | 2023 | 13084 | 0.610 |
Why?
|
Hepacivirus | 11 | 2020 | 1342 | 0.610 |
Why?
|
Aspirin | 5 | 2024 | 3135 | 0.600 |
Why?
|
Thinness | 1 | 2021 | 483 | 0.590 |
Why?
|
Liver Diseases | 3 | 2018 | 1304 | 0.590 |
Why?
|
Weight Loss | 9 | 2020 | 2713 | 0.580 |
Why?
|
Biopsy | 16 | 2022 | 6808 | 0.580 |
Why?
|
Sleep Apnea, Obstructive | 3 | 2015 | 1891 | 0.540 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6567 | 0.530 |
Why?
|
Risk Factors | 39 | 2024 | 74962 | 0.520 |
Why?
|
Middle Aged | 75 | 2024 | 223491 | 0.510 |
Why?
|
Aspartate Aminotransferases | 4 | 2019 | 414 | 0.490 |
Why?
|
Humans | 142 | 2024 | 768393 | 0.470 |
Why?
|
Fibrosis | 10 | 2023 | 2077 | 0.460 |
Why?
|
Lipids | 5 | 2022 | 3344 | 0.460 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2023 | 12241 | 0.450 |
Why?
|
Rhizopus | 1 | 2013 | 21 | 0.450 |
Why?
|
Adult | 64 | 2024 | 223640 | 0.450 |
Why?
|
Alanine Transaminase | 5 | 2021 | 605 | 0.440 |
Why?
|
Esophageal Neoplasms | 3 | 2019 | 1676 | 0.440 |
Why?
|
Male | 85 | 2024 | 364902 | 0.430 |
Why?
|
International Cooperation | 1 | 2019 | 1438 | 0.410 |
Why?
|
Disease Progression | 17 | 2023 | 13646 | 0.410 |
Why?
|
Female | 85 | 2024 | 397089 | 0.410 |
Why?
|
Mucormycosis | 1 | 2013 | 102 | 0.410 |
Why?
|
Diabetes Mellitus | 6 | 2023 | 5891 | 0.400 |
Why?
|
Stomach Diseases | 1 | 2013 | 134 | 0.400 |
Why?
|
Hepatitis, Autoimmune | 2 | 2014 | 173 | 0.400 |
Why?
|
Interferon-alpha | 4 | 2015 | 910 | 0.390 |
Why?
|
Overweight | 3 | 2023 | 2445 | 0.390 |
Why?
|
Gene Expression | 2 | 2021 | 7598 | 0.380 |
Why?
|
Body Mass Index | 11 | 2021 | 13052 | 0.380 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 954 | 0.370 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 541 | 0.370 |
Why?
|
Cholesterol, LDL | 5 | 2014 | 2398 | 0.360 |
Why?
|
Sports Medicine | 2 | 2023 | 239 | 0.350 |
Why?
|
Polyethylene Glycols | 4 | 2015 | 1195 | 0.350 |
Why?
|
Deglutition Disorders | 1 | 2016 | 641 | 0.350 |
Why?
|
Cohort Studies | 18 | 2022 | 41795 | 0.340 |
Why?
|
Losartan | 1 | 2011 | 263 | 0.340 |
Why?
|
Ventricular Remodeling | 1 | 2017 | 1281 | 0.330 |
Why?
|
Incidental Findings | 1 | 2014 | 698 | 0.330 |
Why?
|
Stomach | 1 | 2013 | 703 | 0.320 |
Why?
|
Thiolester Hydrolases | 2 | 2020 | 91 | 0.320 |
Why?
|
Cost-Benefit Analysis | 6 | 2019 | 5538 | 0.320 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2783 | 0.310 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3108 | 0.310 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2009 | 113 | 0.310 |
Why?
|
Triglycerides | 5 | 2019 | 2465 | 0.300 |
Why?
|
Fatty Acids | 3 | 2021 | 1815 | 0.300 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11516 | 0.290 |
Why?
|
Disease Management | 1 | 2018 | 2537 | 0.280 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 2763 | 0.280 |
Why?
|
Prevalence | 10 | 2023 | 15872 | 0.270 |
Why?
|
HIV | 7 | 2023 | 1596 | 0.270 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 250 | 0.270 |
Why?
|
Developing Countries | 1 | 2019 | 2903 | 0.270 |
Why?
|
Natural Language Processing | 1 | 2015 | 1202 | 0.270 |
Why?
|
Prospective Studies | 17 | 2024 | 54920 | 0.270 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 749 | 0.270 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26375 | 0.260 |
Why?
|
Aged | 37 | 2024 | 171562 | 0.260 |
Why?
|
Data Mining | 2 | 2021 | 560 | 0.260 |
Why?
|
Macrophage Activation | 2 | 2019 | 556 | 0.250 |
Why?
|
Risk Reduction Behavior | 3 | 2020 | 1118 | 0.250 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2023 | 2911 | 0.240 |
Why?
|
Heart | 2 | 2017 | 4449 | 0.240 |
Why?
|
Electronic Health Records | 3 | 2020 | 4875 | 0.240 |
Why?
|
Logistic Models | 6 | 2021 | 13323 | 0.240 |
Why?
|
Gastric Bypass | 4 | 2018 | 829 | 0.230 |
Why?
|
Alcohol Drinking | 2 | 2020 | 4049 | 0.230 |
Why?
|
Lipoproteins, HDL | 3 | 2014 | 682 | 0.230 |
Why?
|
Algorithms | 4 | 2020 | 14154 | 0.220 |
Why?
|
Hepatitis | 2 | 2023 | 228 | 0.220 |
Why?
|
Metformin | 1 | 2011 | 911 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 5 | 2023 | 1943 | 0.220 |
Why?
|
Glucokinase | 1 | 2023 | 99 | 0.220 |
Why?
|
Uganda | 2 | 2019 | 1351 | 0.210 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15455 | 0.210 |
Why?
|
Fundoplication | 1 | 2003 | 144 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 155 | 0.200 |
Why?
|
Ultrasonography | 1 | 2016 | 6001 | 0.200 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1517 | 0.200 |
Why?
|
Hepatitis, Alcoholic | 1 | 2023 | 110 | 0.190 |
Why?
|
Liver Transplantation | 4 | 2019 | 2400 | 0.190 |
Why?
|
Common Variable Immunodeficiency | 1 | 2022 | 100 | 0.190 |
Why?
|
RNA, Viral | 6 | 2015 | 2866 | 0.190 |
Why?
|
Remission Induction | 2 | 2019 | 2407 | 0.180 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2023 | 162 | 0.180 |
Why?
|
Severity of Illness Index | 11 | 2023 | 15939 | 0.180 |
Why?
|
Models, Biological | 2 | 2021 | 9493 | 0.180 |
Why?
|
Somatotypes | 1 | 2020 | 41 | 0.180 |
Why?
|
Acyl Coenzyme A | 1 | 2020 | 56 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4069 | 0.180 |
Why?
|
Massachusetts | 3 | 2021 | 8902 | 0.180 |
Why?
|
Ribavirin | 3 | 2015 | 395 | 0.170 |
Why?
|
Anticholesteremic Agents | 2 | 2018 | 972 | 0.170 |
Why?
|
ROC Curve | 2 | 2021 | 3623 | 0.170 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2021 | 208 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20765 | 0.170 |
Why?
|
Hypertension, Portal | 1 | 2022 | 230 | 0.170 |
Why?
|
Barrett Esophagus | 1 | 2003 | 494 | 0.170 |
Why?
|
Case-Control Studies | 6 | 2021 | 22296 | 0.170 |
Why?
|
United States | 18 | 2023 | 73150 | 0.160 |
Why?
|
Lipoproteins, LDL | 2 | 2014 | 643 | 0.160 |
Why?
|
Smoking | 1 | 2016 | 9111 | 0.160 |
Why?
|
Double-Blind Method | 8 | 2024 | 12456 | 0.160 |
Why?
|
Growth Substances | 1 | 2021 | 761 | 0.160 |
Why?
|
Biomass | 1 | 2019 | 131 | 0.160 |
Why?
|
Lipogenesis | 1 | 2020 | 216 | 0.160 |
Why?
|
Heating | 1 | 2019 | 104 | 0.150 |
Why?
|
Retrospective Studies | 16 | 2023 | 81801 | 0.150 |
Why?
|
Eicosanoids | 1 | 2020 | 284 | 0.150 |
Why?
|
Public-Private Sector Partnerships | 1 | 2019 | 123 | 0.150 |
Why?
|
Weight Gain | 2 | 2020 | 2356 | 0.150 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2019 | 190 | 0.150 |
Why?
|
Lipoproteins, VLDL | 1 | 2019 | 201 | 0.150 |
Why?
|
Vitamin D | 1 | 2012 | 3310 | 0.150 |
Why?
|
Pentanoic Acids | 1 | 2017 | 19 | 0.150 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 692 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9742 | 0.150 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 208 | 0.150 |
Why?
|
Adrenal Insufficiency | 1 | 2019 | 194 | 0.140 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12558 | 0.140 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39407 | 0.140 |
Why?
|
Liver Function Tests | 2 | 2021 | 526 | 0.140 |
Why?
|
Human Growth Hormone | 1 | 2022 | 648 | 0.140 |
Why?
|
Area Under Curve | 1 | 2021 | 1642 | 0.140 |
Why?
|
Sports | 1 | 2023 | 703 | 0.140 |
Why?
|
Cooking | 1 | 2019 | 312 | 0.140 |
Why?
|
Metabolic Diseases | 1 | 2023 | 684 | 0.140 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.140 |
Why?
|
Hepatocytes | 3 | 2021 | 1245 | 0.140 |
Why?
|
Chenodeoxycholic Acid | 1 | 2017 | 34 | 0.140 |
Why?
|
Exercise | 5 | 2023 | 5946 | 0.140 |
Why?
|
Guanidines | 1 | 2017 | 194 | 0.140 |
Why?
|
E-Selectin | 1 | 2019 | 578 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2003 | 984 | 0.140 |
Why?
|
Organ Specificity | 1 | 2021 | 1967 | 0.130 |
Why?
|
Kenya | 1 | 2019 | 757 | 0.130 |
Why?
|
Program Development | 2 | 2020 | 1298 | 0.130 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 692 | 0.130 |
Why?
|
Platelet Count | 1 | 2019 | 784 | 0.130 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 190 | 0.130 |
Why?
|
Pentoxifylline | 1 | 2016 | 53 | 0.130 |
Why?
|
Treatment Outcome | 12 | 2019 | 65379 | 0.130 |
Why?
|
Cholangitis | 1 | 2017 | 110 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2890 | 0.130 |
Why?
|
Jejunum | 1 | 2018 | 475 | 0.130 |
Why?
|
Up-Regulation | 2 | 2023 | 4142 | 0.130 |
Why?
|
Blood Proteins | 1 | 2021 | 1186 | 0.130 |
Why?
|
Atherosclerosis | 3 | 2024 | 3431 | 0.130 |
Why?
|
Health Personnel | 1 | 2009 | 3380 | 0.130 |
Why?
|
Carrier Proteins | 2 | 2019 | 4936 | 0.130 |
Why?
|
Incidence | 6 | 2021 | 21544 | 0.120 |
Why?
|
Lipid Metabolism | 3 | 2020 | 1901 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 710 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2019 | 1133 | 0.120 |
Why?
|
Trientine | 1 | 2014 | 12 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1674 | 0.120 |
Why?
|
Thyroid Hormones | 1 | 2018 | 407 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2020 | 848 | 0.120 |
Why?
|
Diastole | 1 | 2017 | 784 | 0.120 |
Why?
|
Comorbidity | 6 | 2022 | 10588 | 0.120 |
Why?
|
Particle Size | 1 | 2019 | 1653 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2020 | 14737 | 0.120 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 11918 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3252 | 0.120 |
Why?
|
Hepatolenticular Degeneration | 1 | 2014 | 73 | 0.120 |
Why?
|
Remission, Spontaneous | 1 | 2015 | 385 | 0.120 |
Why?
|
Anti-Inflammatory Agents | 1 | 2024 | 1813 | 0.120 |
Why?
|
Program Evaluation | 2 | 2020 | 2505 | 0.110 |
Why?
|
Attitude | 1 | 2019 | 772 | 0.110 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2596 | 0.110 |
Why?
|
Melena | 1 | 2013 | 32 | 0.110 |
Why?
|
Down-Regulation | 1 | 2021 | 2940 | 0.110 |
Why?
|
Palliative Care | 2 | 2019 | 3643 | 0.110 |
Why?
|
Peroxidase | 1 | 2017 | 609 | 0.110 |
Why?
|
Lipase | 1 | 2016 | 321 | 0.110 |
Why?
|
Forecasting | 2 | 2020 | 2948 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2021 | 14784 | 0.110 |
Why?
|
Health Care Costs | 2 | 2017 | 3267 | 0.110 |
Why?
|
Stomach Ulcer | 1 | 2013 | 120 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 590 | 0.110 |
Why?
|
Adolescent | 12 | 2024 | 89184 | 0.110 |
Why?
|
Coronary Angiography | 2 | 2022 | 4537 | 0.110 |
Why?
|
Transaminases | 1 | 2014 | 199 | 0.110 |
Why?
|
Adiposity | 2 | 2021 | 1895 | 0.110 |
Why?
|
Cholesterol | 2 | 2014 | 2912 | 0.110 |
Why?
|
Epidermal Growth Factor | 1 | 2016 | 698 | 0.110 |
Why?
|
Anorexia | 1 | 2013 | 152 | 0.110 |
Why?
|
Diagnosis, Differential | 5 | 2017 | 13020 | 0.100 |
Why?
|
Anti-Obesity Agents | 1 | 2016 | 240 | 0.100 |
Why?
|
Cecum | 1 | 2013 | 231 | 0.100 |
Why?
|
Chelating Agents | 1 | 2014 | 385 | 0.100 |
Why?
|
Heart Failure | 1 | 2017 | 11858 | 0.100 |
Why?
|
Blood Glucose | 2 | 2021 | 6430 | 0.100 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11120 | 0.100 |
Why?
|
Desmosterol | 1 | 2012 | 3 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1534 | 0.100 |
Why?
|
Computational Biology | 2 | 2021 | 3543 | 0.100 |
Why?
|
Markov Chains | 1 | 2016 | 977 | 0.100 |
Why?
|
Cooperative Behavior | 1 | 2019 | 1515 | 0.100 |
Why?
|
Young Adult | 13 | 2024 | 60049 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2018 | 1476 | 0.100 |
Why?
|
Air Pollution, Indoor | 1 | 2019 | 915 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1915 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2009 | 6510 | 0.090 |
Why?
|
Advance Care Planning | 1 | 2019 | 698 | 0.090 |
Why?
|
Hydrocortisone | 1 | 2019 | 1841 | 0.090 |
Why?
|
Insulin Resistance | 2 | 2016 | 3981 | 0.090 |
Why?
|
Osteoporosis | 1 | 2021 | 1606 | 0.090 |
Why?
|
Interleukins | 1 | 2016 | 796 | 0.090 |
Why?
|
Proteomics | 2 | 2023 | 3906 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2016 | 1195 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 4 | 2019 | 1735 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 827 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 1999 | 2050 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2018 | 7880 | 0.090 |
Why?
|
Radiology Information Systems | 1 | 2014 | 533 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12092 | 0.080 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 887 | 0.080 |
Why?
|
Growth Hormone | 2 | 2023 | 573 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2015 | 924 | 0.080 |
Why?
|
Blood-Borne Pathogens | 1 | 2009 | 52 | 0.080 |
Why?
|
Amantadine | 1 | 2009 | 59 | 0.080 |
Why?
|
Life Style | 2 | 2021 | 3929 | 0.080 |
Why?
|
Adipose Tissue | 2 | 2021 | 3334 | 0.080 |
Why?
|
Needlestick Injuries | 1 | 2009 | 71 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3666 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1412 | 0.080 |
Why?
|
Odds Ratio | 2 | 2023 | 9682 | 0.080 |
Why?
|
Hypertension | 1 | 2009 | 8615 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9510 | 0.080 |
Why?
|
Virus Activation | 1 | 2010 | 322 | 0.080 |
Why?
|
Prognosis | 6 | 2020 | 30022 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2013 | 863 | 0.070 |
Why?
|
Acute Disease | 2 | 2011 | 7242 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2018 | 3230 | 0.070 |
Why?
|
Epidemics | 1 | 2014 | 517 | 0.070 |
Why?
|
Antioxidants | 1 | 2016 | 1673 | 0.070 |
Why?
|
Antigens, CD | 1 | 2018 | 4031 | 0.070 |
Why?
|
Documentation | 1 | 2014 | 917 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 839 | 0.070 |
Why?
|
Macrophages | 2 | 2019 | 5796 | 0.070 |
Why?
|
Diarrhea | 1 | 2014 | 1320 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4411 | 0.070 |
Why?
|
History, 21st Century | 1 | 2014 | 1575 | 0.070 |
Why?
|
Reproducibility of Results | 6 | 2024 | 20224 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2819 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 695 | 0.070 |
Why?
|
Abdominal Pain | 1 | 2013 | 1070 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1753 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12778 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 530 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2015 | 2448 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2755 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8562 | 0.070 |
Why?
|
Placebos | 2 | 2021 | 1668 | 0.070 |
Why?
|
Risk Assessment | 6 | 2020 | 24318 | 0.070 |
Why?
|
Risk | 2 | 2017 | 9636 | 0.070 |
Why?
|
Data Collection | 1 | 2015 | 3324 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2010 | 413 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1367 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2003 | 6406 | 0.060 |
Why?
|
Genotype | 5 | 2016 | 13042 | 0.060 |
Why?
|
Mice | 10 | 2023 | 82017 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2019 | 3627 | 0.060 |
Why?
|
Obesity, Abdominal | 2 | 2021 | 375 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3267 | 0.060 |
Why?
|
Electrocardiography | 1 | 1999 | 6409 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6606 | 0.060 |
Why?
|
Viral Load | 3 | 2015 | 3398 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18362 | 0.060 |
Why?
|
Echocardiography | 1 | 2017 | 5044 | 0.060 |
Why?
|
Ventricular Function, Left | 1 | 2017 | 3941 | 0.060 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1820 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.060 |
Why?
|
Inflammation | 3 | 2023 | 10863 | 0.060 |
Why?
|
Intra-Abdominal Fat | 2 | 2021 | 624 | 0.050 |
Why?
|
Tandem Mass Spectrometry | 2 | 2020 | 1197 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2020 | 59686 | 0.050 |
Why?
|
Time Factors | 6 | 2019 | 40272 | 0.050 |
Why?
|
Quality of Life | 5 | 2023 | 13503 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3107 | 0.050 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1376 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2491 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Primary Health Care | 2 | 2020 | 4748 | 0.050 |
Why?
|
Animals | 11 | 2023 | 169337 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8541 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3857 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2023 | 462 | 0.040 |
Why?
|
Chronic Disease | 4 | 2019 | 9379 | 0.040 |
Why?
|
Diacylglycerol O-Acyltransferase | 1 | 2020 | 21 | 0.040 |
Why?
|
PPAR alpha | 1 | 2021 | 177 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4614 | 0.040 |
Why?
|
Glucose | 2 | 2023 | 4352 | 0.040 |
Why?
|
Databases, Factual | 1 | 2016 | 8075 | 0.040 |
Why?
|
Pituitary-Adrenal Function Tests | 1 | 2019 | 30 | 0.040 |
Why?
|
Pilot Projects | 2 | 2013 | 8731 | 0.040 |
Why?
|
Globulins | 1 | 2019 | 19 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 384 | 0.040 |
Why?
|
Smad Proteins | 1 | 2020 | 157 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3804 | 0.040 |
Why?
|
DNA, Viral | 1 | 2006 | 2205 | 0.040 |
Why?
|
Nurses | 2 | 2020 | 2494 | 0.040 |
Why?
|
Sulfonylurea Compounds | 1 | 2021 | 220 | 0.040 |
Why?
|
Charcoal | 1 | 2019 | 67 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16028 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
Occupational Exposure | 1 | 2009 | 1817 | 0.040 |
Why?
|
Coal | 1 | 2019 | 122 | 0.040 |
Why?
|
Streptokinase | 1 | 1999 | 186 | 0.040 |
Why?
|
Wood | 1 | 2019 | 92 | 0.040 |
Why?
|
Hyperplasia | 1 | 2022 | 1153 | 0.040 |
Why?
|
Mass Screening | 2 | 2011 | 5451 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2020 | 501 | 0.040 |
Why?
|
Tissue Donors | 2 | 2020 | 2389 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5949 | 0.040 |
Why?
|
Myocardial Reperfusion | 1 | 1999 | 339 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1160 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2021 | 637 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 873 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23631 | 0.030 |
Why?
|
Immunity | 1 | 2023 | 1003 | 0.030 |
Why?
|
Ethanol | 1 | 2023 | 1332 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22355 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2020 | 1539 | 0.030 |
Why?
|
Trans-Activators | 2 | 2016 | 2856 | 0.030 |
Why?
|
Shear Strength | 1 | 2017 | 160 | 0.030 |
Why?
|
Coronary Disease | 1 | 2011 | 5924 | 0.030 |
Why?
|
Elastic Modulus | 1 | 2017 | 211 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 835 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 935 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9261 | 0.030 |
Why?
|
Cultural Competency | 1 | 2019 | 303 | 0.030 |
Why?
|
Hepatic Stellate Cells | 1 | 2016 | 117 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 997 | 0.030 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2015 | 119 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1380 | 0.030 |
Why?
|
Transcription Factors | 3 | 2023 | 12166 | 0.030 |
Why?
|
Time | 1 | 2017 | 546 | 0.030 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2021 | 1149 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2020 | 886 | 0.030 |
Why?
|
Benzylamines | 1 | 2015 | 251 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14481 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.030 |
Why?
|
Benzoates | 1 | 2015 | 213 | 0.030 |
Why?
|
Waiting Lists | 1 | 2019 | 780 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2017 | 1705 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 756 | 0.030 |
Why?
|
Thrombophilia | 1 | 2016 | 306 | 0.030 |
Why?
|
Spine | 1 | 2021 | 1141 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 823 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1141 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2020 | 941 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2460 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15881 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4941 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 1999 | 1163 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10377 | 0.030 |
Why?
|
Gene Deletion | 1 | 2020 | 2673 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6318 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2017 | 499 | 0.030 |
Why?
|
Internationality | 1 | 2018 | 1008 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1512 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1067 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2020 | 1421 | 0.020 |
Why?
|
Interferons | 1 | 2016 | 716 | 0.020 |
Why?
|
Copper | 1 | 2014 | 369 | 0.020 |
Why?
|
Marital Status | 1 | 2013 | 426 | 0.020 |
Why?
|
Career Choice | 1 | 2018 | 769 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 770 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2017 | 1680 | 0.020 |
Why?
|
Pulmonary Fibrosis | 1 | 2015 | 506 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1627 | 0.020 |
Why?
|
Gastrectomy | 1 | 2016 | 696 | 0.020 |
Why?
|
Nausea | 1 | 2014 | 682 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4039 | 0.020 |
Why?
|
Diet | 2 | 2021 | 8090 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2020 | 1467 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1682 | 0.020 |
Why?
|
Child | 2 | 2020 | 80891 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2021 | 2122 | 0.020 |
Why?
|
Hepatitis Antibodies | 1 | 2010 | 67 | 0.020 |
Why?
|
New England | 1 | 2013 | 1058 | 0.020 |
Why?
|
Diuretics | 1 | 2013 | 612 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1503 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3520 | 0.020 |
Why?
|
Postoperative Care | 1 | 2016 | 1480 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2646 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1459 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 2021 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2009 | 151 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1962 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4353 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2021 | 3203 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36849 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2013 | 641 | 0.020 |
Why?
|
Models, Economic | 1 | 2013 | 718 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4859 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10117 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 3707 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18048 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3960 | 0.020 |
Why?
|
Serologic Tests | 1 | 2010 | 383 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 3048 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1739 | 0.020 |
Why?
|
Bone Density | 1 | 2021 | 3559 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13697 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 767 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4834 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5099 | 0.020 |
Why?
|
Myocardium | 1 | 1999 | 4788 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3139 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15597 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12422 | 0.020 |
Why?
|
Graft Survival | 1 | 2016 | 3900 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3922 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1597 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6210 | 0.010 |
Why?
|
Communication | 1 | 2019 | 3912 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10776 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4427 | 0.010 |
Why?
|
Sex Factors | 1 | 2018 | 10654 | 0.010 |
Why?
|
Virus Replication | 1 | 2012 | 2458 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6541 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18471 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5336 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17135 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3438 | 0.010 |
Why?
|
Rats | 1 | 2019 | 23835 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2598 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16721 | 0.010 |
Why?
|
Graft Rejection | 1 | 2016 | 4505 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5375 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8051 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 19022 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7453 | 0.010 |
Why?
|
Gamma Rays | 1 | 1960 | 319 | 0.000 |
Why?
|
Equipment and Supplies | 1 | 1960 | 273 | 0.000 |
Why?
|
Radiometry | 1 | 1960 | 817 | 0.000 |
Why?
|